Literature DB >> 29607785

The Use of Probiotics in Different Phases of Diverticular Disease.

Veronica Ojetti1, Carmine Petruzziello1, Silvia Cardone1, Luisa Saviano1, Alessio Migneco1, Luca Santarelli1, Maurizio Gabrielli1, Raffaella Zaccaria1, Loris Lopetuso2, Marcello Covino1, Marcello Candelli1, Antonio Gasbarrini2, Francesco Franceschi1.   

Abstract

BACKGROUND & AIMS: Diverticular Disease (DD) is a common clinical condition with a dramatic increasing of the prevalence among industrialized countries. Based on the most used classification, DD may be divided into asymptomatic diverticulosis, symptomatic uncomplicated diverticular disease and complicated diverticular disease. Since recent studies pointed out the role of GUT microbiota imbalance in promoting diverticular formation and inflammation, we have designed a systematic review focusing on the possible role of probiotics in the management of this condition.
METHODS: According to PRISMA, we identified studies on DD patients treated with probiotics, by searching on Pubmed, Embase, Cochrane and ResearchGate.
RESULTS: 13 studies were included in this review based on our selection criteria: 3 double-blind randomized placebo-controlled, 6 open randomized, and 4 non-randomized open studies.
CONCLUSION: This is the first systematic review providing an updated measure of evidence on the efficacy of probiotics in a different phase of DD. Even though the majority of studies are still preliminary, current data show a possible clinical application of certain probiotic strains in all stages of DD. Further investigation is then required to better understand when and how probiotics can be used in different phases of DD. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Diverticular disease; GUT microbiota imbalance; PRISMA; probiotics; remission; review.

Mesh:

Year:  2018        PMID: 29607785     DOI: 10.2174/1574887113666180402143140

Source DB:  PubMed          Journal:  Rev Recent Clin Trials        ISSN: 1574-8871


  4 in total

1.  Impact of Oral Probiotics in Amelioration of Immunological and Inflammatory Responses on Experimentally Induced Acute Diverticulitis.

Authors:  Maha G Soliman; Hanaa A Mansour; Wedad A Hassan; Eman Shawky
Journal:  Probiotics Antimicrob Proteins       Date:  2022-07-15       Impact factor: 5.265

Review 2.  Gut Microbiota and Acute Diverticulitis: Role of Probiotics in Management of This Delicate Pathophysiological Balance.

Authors:  Andrea Piccioni; Laura Franza; Mattia Brigida; Christian Zanza; Enrico Torelli; Martina Petrucci; Rebecca Nicolò; Marcello Covino; Marcello Candelli; Angela Saviano; Veronica Ojetti; Francesco Franceschi
Journal:  J Pers Med       Date:  2021-04-14

3.  Development and Validation of Predictive Assessment of Complicated Diverticulitis Score.

Authors:  Marcello Covino; Valerio Papa; Antonio Tursi; Benedetta Simeoni; Loris Riccardo Lopetuso; Lorenzo Maria Vetrone; Francesco Franceschi; Gianludovico Rapaccini; Antonio Gasbarrini; Alfredo Papa
Journal:  J Pers Med       Date:  2021-01-29

Review 4.  Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease.

Authors:  Elisabetta Bretto; Ferdinando D'Amico; Walter Fiore; Antonio Tursi; Silvio Danese
Journal:  J Clin Med       Date:  2022-03-30       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.